Searchable abstracts of presentations at key conferences in endocrinology

ea0016p742 | Thyroid | ECE2008

Iodine metabolism and effect of 131I therapy in Graves’ disease

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria

The factors influencing the final outcomes of 131I therapy are indefinitely known, besides its practical use since more than 60 years. One of the considered factors affecting the results of 131I therapy is iodine metabolism.Aim: The aim of the study was the evaluation of the iodine uptake and the effective half-life of 131I influence on the result of radioactive iodine therapy in patients treated due to Graves’ hyper...

ea0026p434 | Thyroid (non cancer) | ECE2011

Autoimmune hyperthyroidism triggered by 131I treatment for toxic nodular goitre: treatment with a second dose of 131I versus thyrostatics

Kijek Jolanta , St Tarach Jerzy , Szymanek Bozena , Kurowska Maria

The transformation of toxic nodular goitre into autoimmune hyperthyroidism with development of thyrotropin receptor antibodies (TSHRAb) as effect of 131I therapy is rarely investigated.The aim of the study is to present cases of patients with toxic nodular goitre who developed autoimmune hyperthyroidism after initial 131I dose, and results of treatment with second 131I dose or thyrostatics.Four pati...

ea0022p222 | Clinical case reports and clinical practice | ECE2010

A retroperitoneal neuroendocrine tumour pre-diagnosed as an adrenal incidentaloma - a case report

Malicka Joanna , Kurowska Maria , Tarach Jerzy , Kijek Jolanta

Introduction: Neoplastic lesions in the retroperitoneum may originate from kidneys, ureters, adrenal glands or peripheral nervous, connective, muscle and adipose tissues. Neuroendocrine tumours are exceptionally located in the retroperitoneum.The case study: A woman aged 51, with a tumour of the left adrenal gland found incidentally during an ultrasound examination of the abdominal cavity, which was performed because of dysuria. A CT confir...

ea0020p122 | Thyroid | ECE2009

The TSH receptor antibody levels (TSHRAb) and thyroid function after 131I therapy in patients with Graves’ disease – 10 years follow-up

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Szymanek Bozena

Aim: The aim of the study was the evaluation of the TSHRAb level changes and the comparison with thyroid function in patients with Graves’ disease treated with 131I 10 years ago.Material and methods: The study has been conducted in 67 patients (57 women, 10 men) aged 27–72 y (mean 48 years) with Graves’ disease.All patients were treated with 131I due to hyperthyroidism confirmed by fT3, fT4 and ...

ea0020p123 | Thyroid | ECE2009

The outcome of radioiodine therapy in Graves’ hyperthyroidism: thyroid size as prognostic factor

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Jankowska Helena

Aim: The aim of the study was the evaluation of the relationship between thyroid size and the result of radioactive iodine therapy in patients treated due to Graves’ hyperthyroidism.Material and methods: The study group included 150 subjects (127 M and 23 F), aged from 20 to 78 years (mean 48.33 years) at the moment of 131I therapy.In all patients the thyroid technetium-99m scan and determination of the serum levels...

ea0020p155 | Thyroid | ECE2009

Iodine metabolism in hyperthyroidism

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Chrapko Beata

Introduction: Iodine is critical for thyroid morphology and function. On the one hand, iodine is a factor leading and permitting to origin of disturbances of thyroid follicular cells function, on the other hand, it’s therapeutic agent.Aim: The aim of the study was to evaluate iodine metabolism in different forms of hyperthyroidism and to analyze relationship between metabolism and thyroid size and function.Material and methods...

ea0016p702 | Thyroid | ECE2008

The outcome of radioiodine therapy of hyperthyroidism: comparison of patients with a toxic nodular goiter and with Graves' disease

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria , Szymanek Bozena

Introduction: Hyperthyroidism is one of frequently encountered clinical syndromes appearing in about 2% of adult population. The aim of this study was to evaluate the efficacy of radioiodine treatment in relation to the form of hyperthyroidism.Material and methods: The study investigated 300 patients: 150 with Graves’ disease and 150 with a toxic adenoma goiter (109 with a solitary nodule and 41 with a multinodular goiter). In all the cases, the est...

ea0041ep1069 | Thyroid (non-cancer) | ECE2016

The efficacy of Radioiodine Therapy in Patients with Graves’ Disease

Dabrowska Anna , Kijek Jolanta , Tarach Jerzy , Torun-Jurkowska Anna , Chrapko Beata , Kurowska Maria

Introduction: Radioiodine (RAI) has been used for the treatment of Graves’ hyperthyroidism since 1940s. It is relatively safe and considered as one of the definitive therapies. Achievement of hypothyroidism or euthyroidism is defined as a successful therapy.Methods: The study was conducted in 366 patients (80.60% of women) with Graves’ disease (GD), aged 46.76±13.52 years. We analyzed retrospectively hormonal and imaging findings (scintigr...

ea0041ep1081 | Thyroid (non-cancer) | ECE2016

The efficacy of radioiodine therapy in patients with hyperfunctioning thyroid nodules

Dabrowska Anna , Kijek Jolanta , Tarach Jerzy , Torun-Jurkowska Anna , Chrapko Beata , Kurowska Maria

Introduction: Radioiodine (RAI) is used as a definitive therapy of hyperthyroidism due to toxic adenoma (TA) as well as toxic multinodular goiter (TMG). Achievement of hypothyroidism or euthyroidism is defined as a successful therapy.Methods: The study was conducted in 666 patients – 484 with TA and 182 with TMG (85.58% of women), aged 56.19±13.88 years. We analyzed retrospectively hormonal and imaging findings (scintigraphy, ultrasonography), ...

ea0035p566 | Endocrine tumours and neoplasia | ECE2014

Primary neuroendocrine carcinoma of renal: a rare case report

Budlewski Tadeusz , Szydlarska Dorota , Szalus Norbert , Kijek Jolanta , Chrapko Beata Ewa

We report a case of local recurrence and multiple lymph node and pulmonary metastases of renal carcinoid 1 year after nephrectomy in a 61-year-old woman. Primary renal carcinoid tumor arising from renal parenchyma or renal pelvis is a rare neoplasm. The patient was incidentally found to have a mass lesion in the left kidney and left nephrectomy was performed. Histological examination including immunohistochemical for chromogranin A and synaptophysin studies confirmed the diagn...